Olumiant Interactions
There are 488 drugs known to interact with Olumiant (baricitinib), along with 10 disease interactions. Of the total drug interactions, 330 are major, 151 are moderate, and 7 are minor.
- View all 488 medications that may interact with Olumiant
- View Olumiant disease interactions (10)
Most frequently checked interactions
View interaction reports for Olumiant (baricitinib) and the medicines listed below.
- amitriptyline
- amlodipine
- atorvastatin
- buspirone
- Celebrex (celecoxib)
- Cymbalta (duloxetine)
- duloxetine
- folic acid
- gabapentin
- hydroxychloroquine
- hydroxyzine
- leflunomide
- levothyroxine
- lisinopril
- losartan
- Lyrica (pregabalin)
- meloxicam
- metformin
- methotrexate
- omeprazole
- Orencia (abatacept)
- pantoprazole
- prednisone
- propranolol
- Rinvoq (upadacitinib)
- Synthroid (levothyroxine)
- tramadol
- trazodone
- turmeric
- Vitamin D3 (cholecalciferol)
Olumiant disease interactions
There are 10 disease interactions with Olumiant (baricitinib) which include:
- infections
- tuberculosis
- cardiovascular risk
- malignancy
- thrombosis
- GI perforation
- hepatic impairment
- laboratory abnormalities
- renal dysfunction
- viral hepatitis
More about Olumiant (baricitinib)
- Olumiant consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (13)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.